Company profile: LSL Pharma
1.1 - Company Overview
Company description
- Provider of life sciences manufacturing, offering turnkey formulation, development and manufacturing of sterile pharmaceutical products (including ointments) for hospitals, pharmacies and the animal health sector, and natural health products (including solid tablets).
Products and services
- Natural Health Products (solid-dose): Engineers and fabricates tablets in solid form, offering formulation, development, and manufacturing services for natural health categories across life sciences
- Steri-Med Pharmaceutical Products (sterile-grade): Engineers and produces sterile pharmaceutical products, including ointments, supplying hospitals, pharmacies, and the animal health sector with sterile formulations
- Formulation, Development and Manufacturing Services (turnkey): Delivers turnkey formulation, development, and manufacturing services for life sciences products, including natural health products such as tablets in solid form, integrating subsidiary expertise
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LSL Pharma
FairJourney Biologics
HQ: Portugal
Website
- Description: Provider of end-to-end antibody discovery and development solutions, leveraging top-tier technologies and seasoned researchers to deliver high-quality, reliable antibodies tailored to partner needs. Services include customized cell line engineering for research and support from discovery to clinical trials; organizer of The Antibody Series on innovations in antibody discovery and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FairJourney Biologics company profile →
TKL Research
HQ: United States
Website
- Description: Provider of a fully integrated network of clinical research centers serving pharmaceutical, biotechnology, medical device, and consumer healthcare industries, offering inpatient and outpatient capabilities, including two purpose-built phase I clinical pharmacology units and five outpatient clinics equipped for phase II–IV clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TKL Research company profile →
Northeast Biolab
HQ: United States
Website
- Description: Provider of GLP and clinical bioanalysis services with 15+ years of experience, offering method development, validation and transfer; LC-MS bioanalysis; pharmacokinetics sample analysis and toxicokinetic safety testing; and assay platforms including ELISA, MSD, qPCR/ddPCR, Western Blot and In Cell Western for drug testing and biomarker analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Northeast Biolab company profile →
CBPartners
HQ: United States
Website
- Description: Provider of strategy consulting services focused on strategic issues for multinational pharmaceutical, biopharmaceutical, and medical device companies, as well as governments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CBPartners company profile →
Vibalogics
HQ: Germany
Website
- Description: Provider of contract development and manufacturing services for live biological products, including process development, manufacturing and fill & finish for oncolytic viruses, gene therapies and vaccines. Capabilities span viral vector and live virus production, RNA and LNP manufacturing, plasmid development and manufacturing, upstream/downstream and formulation development, and cGMP manufacturing for phase 1–2 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vibalogics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LSL Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LSL Pharma
2.2 - Growth funds investing in similar companies to LSL Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LSL Pharma
4.2 - Public trading comparable groups for LSL Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →